Search results
Results from the WOW.Com Content Network
Streptomyces olivaceus is a bacterium species from the genus of Streptomyces which has been isolated from soil. [1] [3] [4] Streptomyces olivaceus produces granaticin, elloramycin, tetroazolemycin A and tetroazolemycin B. [5] [6] [7] Streptomyces olivaceus can be used to produce vitamin B12. [8] [9]
Streptomycin is an antibiotic medication used to treat a number of bacterial infections, [3] including tuberculosis, Mycobacterium avium complex, endocarditis, brucellosis, Burkholderia infection, plague, tularemia, and rat bite fever. [3] For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide. [4]
Streptomyces is the largest genus of Actinomycetota, and the type genus of the family Streptomycetaceae. [3] Over 700 species of Streptomyces bacteria have been described. [4] [5] [6] As with the other Actinomycetota, streptomycetes are gram-positive, and have very large genomes with high GC content.
Streptomyces isolates have yielded the majority of human, animal, and agricultural antibiotics, as well as a number of fundamental chemotherapy medicines.Streptomyces is the largest antibiotic-producing genus of Actinomycetota, producing chemotherapy, antibacterial, antifungal, antiparasitic drugs, and immunosuppressants. [1]
The lipoglycopeptide dalbavancin and the oxazolidinone tedizolid has also been approved for use for the treatment of acute bacterial skin and skin structure infection. The first in a new class of narrow-spectrum macrocyclic antibiotics, fidaxomicin, has been approved for the treatment of C. difficile colitis. [162]
Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some Mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Streptomycin was the first effective drug in the treatment of tuberculosis, though ...
To make these medicines widely available without breaking the bank, the U.S. Food and Drug Administration (FDA) should do what it already does with some insulin products: Let consumers buy them ...
Lincomycin is a narrow spectrum antibiotic with activity against Gram-positive and cell wall-less bacteria including pathogenic species of Streptococcus, Staphylococcus, and Mycoplasma. [7] Lincomycin is used to treat severe bacterial infections in patients who cannot use penicillin antibiotics.